Delivery Order SPE2DB22D2218-SPE2DB24FR2VU

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The $17,486.92 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 13, 2024, with a completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,614.21, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,726.91 firm fixed-price delivery order is for XELJANZ XR 11 MG TABLET with an ultimate completion date of May 30, 2024. The contract is not set aside for any specific business category. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,304.49 firm fixed-price delivery order contract is for the supply of XELJANZ XR 11 MG tablets. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,741.48 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,103.71 firm-fixed-price delivery order is for XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,234.43 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,674.83 firm fixed-price delivery order is for the provision of XELJANZ XR 11 MG TABLET medical supplies. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of XELJANZ XR 11 MG TABLET UU 30S, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,830.48 firm-fixed-price delivery order has a completion date of December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S to support various government healthcare programs. The $5,844.29 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 17, 2024. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
  • SPE2DB22D2218
    Indefinite Delivery Contract
  • SPE2DB22D2218-SPE2DB24FR2VU
    Delivery Order

This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product XELJANZ XR 11 MG TABLET. The $3,537.53 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 10, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/8/24, 9:14 AM